R

Regeneron Pharmaceuticals, Inc. (REGN)

NMS – Real Time Price. Currency in USD

632.90

+12.76 (2.06%)

At close: Jun 26, 2026, 4:00 PM EDT

631.38

-1.52 (-0.24%)

After-hours: Jun 26, 2026, 7:38 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Regeneron Pharmaceuticals, Inc. (REGN)

NMS – Real Time Price. Currency in USD

632.90

+12.76 (2.06%)

At close: Jun 26, 2026, 4:00 PM EDT

631.38

-1.52 (-0.24%)

After-hours: Jun 26, 2026, 7:38 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

14.34B

14.20B

13.12B

12.17B

Cost of goods sold

-2.64B

-2.45B

-2.24B

-1.71B

Gross Profit

11.70B

11.75B

10.87B

10.47B

Operating expenses (excl. COGS)

-8B

-7.58B

-6.52B

-5.08B

Operating Income

3.70B

4.17B

4.35B

5.39B

Non-operating income, total

1.53B

606M

-149M

-527M

Pretax income

5.23B

4.78B

4.20B

4.86B

Equity in earnings

-

Taxes

-726M

-367M

-246M

-520M

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

4.50B

4.41B

3.95B

4.34B

Search stocks

Regeneron Pharmaceuticals, Inc. (REGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Regeneron Pharmaceuticals, Inc. (REGN)

Income Statement (Annual)